Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)

Sponsor
Optovue (Industry)
Overall Status
Completed
CT.gov ID
NCT04437082
Collaborator
(none)
143
1
3.4
41.5

Study Details

Study Description

Brief Summary

The purpose of this study is to assess performance of measurements of anatomical and vascular structures of the eye based on OCT and OCTA scans in normal subjects and eyes with pathology.

Condition or Disease Intervention/Treatment Phase
  • Device: optical coherence tomography

Study Design

Study Type:
Observational
Actual Enrollment :
143 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Performance Evaluation of OCT and OCTA-based Ocular Measurements
Actual Study Start Date :
Jan 15, 2021
Actual Primary Completion Date :
Apr 30, 2021
Actual Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Normal

no pre-existing conditions

Device: optical coherence tomography
imaging structural and vascular features of the eye

Glaucoma

diagnosis of glaucoma

Device: optical coherence tomography
imaging structural and vascular features of the eye

Retina

diagnosis of retina pathology

Device: optical coherence tomography
imaging structural and vascular features of the eye

Cornea

diagnosis of corneal condition

Device: optical coherence tomography
imaging structural and vascular features of the eye

Outcome Measures

Primary Outcome Measures

  1. Standard Deviation [Day 1]

    measure of variance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Normal - No pre-existing conditions.

  • Glaucoma - Diagnosis of glaucoma.

  • Retina - Diagnosis of retinal pathology

  • Cornea - Diagnosis of clinic condition.

Exclusion Criteria:
  • Unable to complete required exams.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oklahoma College of Optometry, Northeastern State University Tahlequah Oklahoma United States 74464

Sponsors and Collaborators

  • Optovue

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Optovue
ClinicalTrials.gov Identifier:
NCT04437082
Other Study ID Numbers:
  • 200-54611
First Posted:
Jun 18, 2020
Last Update Posted:
Sep 20, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Sep 20, 2021